Advertisement

Topics

Patheon to Invest $45 Million, Expanding Capabilities to Support Continued Growth

12:00 EDT 29 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Investments in key service areas to meet growing customer demand Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical sector, today announc...

Other Sources for this Article

Patheon
Mari Mansfield, 919-226-3137
Senior Director, External Communications
Mari.Mansfield@Patheon.com
media@patheon.com

NEXT ARTICLE

More From BioPortfolio on "Patheon to Invest $45 Million, Expanding Capabilities to Support Continued Growth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...